Editorial · 31 Dec 2025
Review articlePublished 30 Dec 2023
Covid 19 Treatment by Harpal S. Mangat MD
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
COVID is a fast-mutating virus that understands the dynamics of the ACE 2 pathways. It is a biphasic disease with three tiers of intervention. The initial phase is viremic and is optimal for treatment with anti-viremic drugs that target viral replication in distinct parts of viral replication cycle e.g. protease inhibitors like Lopinavir/ Ritonavir and medications that containerize the COVID particles e.g. hydroxychloroquine. This is supplemented by drying inhalers e.g., Breztri or ipratropium bromide that decrease COVID rich secretions going into the lung alveoli. The addition of H1 blockers e.g., Benadryl prevents the escalation of the bradykinin storm into the cytokine storm. The addition of JAK 2 inhibitors e.g., famotidine shuts down the progression into the cytokine storm. This phase progresses by 8th-10th day if left unchecked to the second phase (the cytokine storm) where the body creates an acute inflammatory response causing severe damage. This results in thrombosis and pulmonary embolism. The second phase requires both antiviral medications, high dose steroids, famotidine, Benadryl, steroid inhalers e.g., Breztri and Pulmicort as well as Interleukin 7 blockers e.g., Tocilizumab if available. Once thrombosis or pulmonary embolism has been identified appropriate anti-thrombotic like Eliquis is essential. The third tier of intervention is identifying and treating the atypical bacteria, viruses and fungi that arise from the immunodeficiency’s that temporally arise from COVID infection.
Keywords
- ACE 2 receptors
- Bradykinin storm
- Hyaluronic acid
- Ground glass
- Pulmonary embolism
- Diarrhea
- Smell
- Taste
- Headache
- Facial nerve
- Mastoiditis
- ACE 2 inhibitors
- ARB blockers
- Ibuprofen
- JAK 2 inhibitors
- Famotidine
- HIV1
- HIV2
- SIMV
- Spike protein
- Viremia
- Cytokine storm
- Thrombosis
- Breztri
- Ipratropium bromide
- Alevesco
- Pulmicort
- Monoclonal antibodies
- Benadryl
- Hydroxychloroquine
- Lopinavir/Ritonavir
- Protease inhibitor
- Nirmatrelvir/Ritonavir
- Remdesivir
- Renal toxic
- Ivermectin
- RNA replicase
- TMPRSS2 inhibitor
- High dose steroids
- Prednisone
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Health Science Journal.
Editorial · 31 Dec 2025
Digestive Balance: Maintaining a Healthy Gut for Optimal Digestion and Well-being
Editorial · 31 Dec 2025
Prebiotics: Exploring the Role of Dietary Components in Supporting Gut Health and Overall Wellness
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHealth Science Journal
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Harpal S. Mangat MD”
